0000000000199678

AUTHOR

Marina Garcés-albir

showing 16 related works from this author

Impact of Postoperative Complications on Survival and Recurrence After Resection of Colorectal Liver Metastases

2019

OBJECTIVE To study the effect of postoperative complications (POC) on overall survival (OS) and disease-free survival (DFS) after surgical resection of colorectal liver metastases (CRLM). SUMMARY BACKGROUND DATA Morbidity rates after liver resection can reach 45%. The negative impact of POC on oncologic outcomes has been reported in various types of cancer, especially colorectal. However, data on the consequences of POC after CRLM resection on long-term survival are scarce. METHODS Eligible studies examining the association between POC after CRLM resection and OS/DFS were sought using the PubMed and Web of Science databases. A random-effects model was used to calculate pooled effect estimat…

Oncologymedicine.medical_specialtymedicine.medical_treatmentSubgroup analysisResection03 medical and health sciencesPostoperative Complications0302 clinical medicineInternal medicinemedicineHepatectomyHumansSurvival rateSurvival analysisbusiness.industryLiver NeoplasmsHazard ratioCancermedicine.diseaseSurvival Rate030220 oncology & carcinogenesisMeta-analysis030211 gastroenterology & hepatologySurgeryNeoplasm Recurrence LocalHepatectomyColorectal NeoplasmsbusinessAnnals of Surgery
researchProduct

Pancreatoduodenectomy with artery-first approach.

2019

"Artery-first approach" encompasses different aspects for the surgical treatment of pancreatic cancer. It is a surgical technique or set of techniques which share in common the dissection of the main arterial vasculature involved in pancreatic cancer, before any irreversible surgical step is performed. On the other hand it represents the need for a meticulous dissection of the arterial planes and clearing of the retropancreatic tissue between the superior mesenteric artery, the common hepatic artery and portal vein in an attempt to achieve R0 resections. The recent expansion of this approach is based mainly on three factors: venous involvement should not be considered a contraindication for…

medicine.medical_specialtymedicine.medical_treatmentPortal veinDissection (medical)PancreaticoduodenectomyContraindications Procedure03 medical and health sciences0302 clinical medicineHepatic ArteryMesenteric Artery Superiormedicine.arteryPancreatic cancermedicineHumansNeoplasm InvasivenessSuperior mesenteric arteryContraindicationPancreasCommon hepatic arterybusiness.industryPortal VeinMargins of ExcisionPancreatic Diseasesmedicine.diseasePancreaticoduodenectomyPrognosisPancreatic Neoplasmsmedicine.anatomical_structureTreatment Outcome030220 oncology & carcinogenesis030211 gastroenterology & hepatologySurgeryRadiologybusinessArteryMinerva chirurgica
researchProduct

Circulating Tumor DNA Detection by Digital-Droplet PCR in Pancreatic Ductal Adenocarcinoma: A Systematic Review

2021

Simple Summary Pancreatic cancer is a digestive tumor that is most difficult to treat and carries one of the worst prognoses. The anatomical location of the pancreas makes it very difficult to obtain enough tumor material to establish a molecular diagnosis, so knowing the biology of this tumor and implementing new targeted-therapies is still a pending issue. The use of liquid biopsy, a blood sample test to detect circulating-tumor DNA fragments (ctDNA), is key to overcoming this difficulty and improving the evolution of this tumor. Liquid biopsies are equally representative of the tissue from which they come and allow relevant molecular and diagnostic information to be obtained in a faster …

0301 basic medicineCancer Researchpancreatic cancerpancreatic ductal adenocarcinoma (PDAC)lcsh:RC254-28203 medical and health sciences0302 clinical medicineCirculating tumor cellPancreatic cancerBiopsydigital-droplet PCR (ddPCR)MedicineLiquid biopsymedicine.diagnostic_testbusiness.industryctDNAmedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensMinimal residual disease030104 developmental biologymedicine.anatomical_structureOncology030220 oncology & carcinogenesisCancer cellCancer researchBiomarker (medicine)Systematic ReviewbusinessPancreasCancers
researchProduct

What does preoperative three-dimensional image contribute to complex pancreatic surgery?

2020

Abstract The possibility of modelling diagnostic images in three dimensions (3D) in pancreatic surgery is a novelty that provides us multiple advantages. A better visualization of the structures allows us a more accurate planning of the surgical technique and makes it easier the surgery in complex cases. We present the case study of a borderline pancreatic head adenocarcinoma patient to illustrate the advantages of 3D modelling in complex pancreatic surgery. The help of 3D technology allowed us to optimally plan the intervention and facilitate surgical resection. The use of this tool could translate into: shorter operative time, fewer intraoperative complications or an increase in R0 resect…

Surgical resectionmedicine.medical_specialtybusiness.industryGeneral EngineeringNoveltyUsabilityAdenocarcinomaPancreatic headPancreatic surgeryVisualizationPancreatic NeoplasmsImaging Three-DimensionalHumansMedicineOperative timeMedical physicsbusinessPancreasDigestive System Surgical ProceduresCirugía Española (English Edition)
researchProduct

Outcome Quality Standards in Pancreatic Oncologic Surgery in Spain

2018

Introduction: To establish quality standards in oncologic surgery is a complex but necessary challenge to improve surgical outcomes. Unlike other tumors, there are no well-defined quality standards in pancreatic cancer. The aim of this study is to identify quality indicators in pancreatic oncologic surgery in Spain as well as their acceptable limits of variability. Methods: Quality indicators were selected based on clinical practice guidelines, consensus conferences, reviews and national publications on oncologic pancreatic surgery between the years 2000 and 2016. Variability margins for each indicator have been determined by statistical process control techniques and graphically represente…

medicine.medical_specialtymedia_common.quotation_subjectPancreatic surgery030230 surgeryOutcome (game theory)Oncologic surgeryPancreatic surgery03 medical and health sciencesPancreatectomy0302 clinical medicinePancreatic cancerOutcome Assessment Health CaremedicineHumansQuality (business)Quality standardsIntensive care medicinePancreasOncologic resectionQuality of Health Caremedia_commonbusiness.industryGeneral Engineeringmedicine.diseaseConfidence intervalPancreatic NeoplasmsSpainHomogeneousSample size determination030220 oncology & carcinogenesisbusinessCirugía Española (English Edition)
researchProduct

Multiple small bowel perforations during the treatment of primary intestinal extranodal natural killer/T‐cell lymphoma, nasal type

2021

Pathologymedicine.medical_specialtybusiness.industryHematologyNasal typeBowel perforationmedicine.diseaseNatural killer T cellmedicine.disease_causeEpstein–Barr virusLymphomaGastrointestinal perforationmedicinebusinessBritish Journal of Haematology
researchProduct

¿Qué aporta la imagen tridimensional preoperatoria en la cirugía pancreática compleja?

2021

Resumen La posibilidad de modelizacion de imagenes diagnosticas en tres dimensiones (3 D) en cirugia pancreatica es una novedad que nos aporta multiples ventajas. Una mejor visualizacion de las estructuras nos permite una planificacion de la tecnica quirurgica mas precisa y nos facilita la realizacion de la cirugia en casos complejos. Presentamos el caso de un paciente diagnosticado de un adenocarcinoma de cabeza de pancreas borderline para ilustrar las ventajas de la modelizacion 3 D en cirugia pancreatica compleja. La ayuda de la tecnologia 3 D nos permitio planificar de manera optima la intervencion facilitando la reseccion quirurgica. El uso de esta herramienta podria traducirse en: men…

03 medical and health sciences0302 clinical medicinebusiness.industryMedicineSurgery030230 surgerybusinessHumanitiesCirugía Española
researchProduct

Borderline resectable pancreatic cancer. Challenges and controversies.

2018

Abstract Pancreatic cancer is a dismal disease with an increasing incidence. Despite the majority of patients are not candidates for curative surgery, a subgroup of patients classified as borderline resectable pancreatic cancer can be selected in whom a sequential strategy of neoadjuvant therapy followed by surgery can provide better outcomes. Multidisciplinary approach and surgical pancreatic expertise are essential for successfully treating these patients. However, the lack of consensual definitions and therapies make the results of studies very difficult to interpret and hard to be implemented in some settings. In this article, we review the challenges of borderline resectable pancreatic…

medicine.medical_specialtybusiness.industryIncidence (epidemiology)medicine.medical_treatmentGeneral surgeryGeneral MedicineDisease030230 surgerymedicine.diseasePancreatic Neoplasms03 medical and health sciences0302 clinical medicineOncologyNeoadjuvant treatmentBorderline resectable030220 oncology & carcinogenesisPancreatic cancerPreoperative CaremedicineCurative surgeryHumansRadiology Nuclear Medicine and imagingbusinessNeoadjuvant therapyCancer treatment reviews
researchProduct

Neoadjuvant treatment for locally advanced unresectable and borderline resectable pancreatic cancer: oncological outcomes at a single academic centre.

2020

INTRODUCTION: Pancreatic cancer (PC), even in the absence of metastatic disease, has a dismal prognosis. One-third of them are borderline resectable (BRPC) or locally advanced unresectable PC (LAUPC) at diagnosis. There are limited prospective data supporting the best approach on these tumours. Neoadjuvant chemotherapy (ChT) is being increasingly used in this setting. METHODS: This is a retrospective series of consecutive patients staged as BRPC or LAUPC after discussion in the multidisciplinary board (MDB) at an academic centre. All received neoadjuvant ChT, followed by chemoradiation (ChRT) in some cases, and those achieving enough downstaging had a curative-intent surgery. Descriptive da…

borderline resectableCancer Researchmedicine.medical_specialtyFOLFIRINOXmedicine.medical_treatmentpancreatic cancerNeutropeniaAdenocarcinomalcsh:RC254-282Pancreatic cancerAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansProspective Studies1506Neoadjuvant therapyRetrospective StudiesOriginal ResearchChemotherapybusiness.industrymedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogenslocally advanced unresectableNeoadjuvant TherapyOxaliplatinSurgeryIrinotecanPancreatic NeoplasmsFOLFIRINOXOncologyFluorouracilbusinessmedicine.drugESMO open
researchProduct

Distal pancreatectomy with multivisceral resection: A retrospective multicenter study - Case series.

2020

Abstract Background Multivisceral resection (MVR) is sometimes necessary to achieve disease-free margins in cancer surgery. In certain patients with pancreatic tumors that invade neighboring organs these must be removed to perform an appropriate oncological surgery. In addition, there is an increasing need to perform resections of other organs like liver not directly invaded by the tumor but which require synchronous removal. The results of MVR in pancreatic surgery are controversial. Material and methods A distal pancreatectomy retrospective multicenter observational study using prospectively compiled data carried out at seven HPB Units. The period study was January 2008 to December 2018. …

AdultMalemedicine.medical_specialty030230 surgery03 medical and health sciencesPancreatic Fistula0302 clinical medicinePancreatectomyBlood lossmedicineHumansAgedRetrospective StudiesTumor sizebusiness.industryMultivisceral resectionCancerGeneral MedicineMiddle Agedmedicine.diseaseSurgeryPancreatic Neoplasmsmedicine.anatomical_structureMulticenter studyPancreatic fistula030220 oncology & carcinogenesisSurgeryFemaleMorbidityPancreasDistal pancreatectomybusinessInternational journal of surgery (London, England)
researchProduct

Estándares de calidad en la cirugía oncológica pancreática en España

2018

Resumen Introduccion Identificar los estandares de calidad en la cirugia oncologica es un reto complejo necesario para poder mejorar los resultados quirurgicos. A diferencia de lo que ocurre en otros tumores, no existen unos estandares de calidad bien definidos en el cancer de pancreas. El objetivo es identificar los indicadores de calidad en la cirugia pancreatica oncologica en Espana, asi como sus limites de variabilidad. Metodos Los indicadores de calidad se han seleccionado a partir de las guias de practica clinica, conferencias de consenso, revisiones y publicaciones de ambito nacional sobre cirugia pancreatica oncologica entre los anos 2000-2016. Los margenes de variabilidad para cada…

03 medical and health sciences0302 clinical medicinebusiness.industry030220 oncology & carcinogenesisMedicineSurgery030230 surgerybusinessHumanitiesCirugía Española
researchProduct

The role of endoscopic retrograde cholangiopancreatography in the management of iatrogenic bile duct injury after cholecystectomy

2019

espanolIntroduccion: la lesion yatrogenica de la via biliar (LYVB) es una complicacion con elevada morbilidad tras la colecistectomia. En los ultimos anos la endoscopia ha adquirido un papel fundamental en el manejo de esta patologia. Metodos: estudio retrospectivo de LYVB tras colecistectomia abierta (CA) o colecistectomia laparoscopica (CL) tratadas en nuestro centro entre 1993 y 2017. Se analizaron los datos referentes a las caracteristicas clinicas, tipo de lesion segun la clasificacion de Strasberg-Bismuth, diagnostico, tecnica de reparacion y seguimiento. Resultados: se estudian 46 pacientes. La incidencia LYVB fue de 0,48%, 0,61% para las CL y 0,24% para las CA. El diagnostico se rea…

AdultMalePrimary suturemedicine.medical_specialtymedicine.medical_treatmentIatrogenic DiseaseOpen cholecystectomyPatient characteristicsSphincterotomy EndoscopicYoung AdultPostoperative ComplicationsmedicineAcute cholecystitisHumansCholecystectomyProspective StudiesLaparoscopic cholecystectomyAgedRetrospective StudiesAged 80 and overCholangiopancreatography Endoscopic RetrogradeGynecologyEndoscopic retrograde cholangiopancreatographymedicine.diagnostic_testBile ductbusiness.industryIncidenceSuture TechniquesGastroenterologyGeneral MedicineMiddle Agedmedicine.anatomical_structureCholecystectomy LaparoscopicFemaleStentsCholecystectomyBile DuctsbusinessRevista Española de Enfermedades Digestivas
researchProduct

Does the Artery-first Approach Improve the Rate of R0 Resection in Pancreatoduodenectomy? A Multicenter, Randomized, Controlled Trial

2019

[Objective]: To compare the rates of R0 resection in pancreatoduodenectomy (PD) for pancreatic and periampullary malignant tumors by means of standard (ST-PD) versus artery-first approach (AFA-PD). [Background]: Standardized histological examination of PD specimens has shown that most pancreatic resections thought to be R0 resections are R1. “Artery-first approach” is a surgical technique characterized by meticulous dissection of arterial planes and clearing of retropancreatic tissue in an attempt to achieve a higher rate of R0. To date, studies comparing AFA-PD versus ST-PD are retrospective cohort or case-control studies. [Methods]: A multicenter, randomized, controlled trial was conducte…

medicine.medical_specialtybusiness.industryTreatment outcomelaw.invention03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureRandomized controlled trialMulticenter studylaw030220 oncology & carcinogenesismedicine030211 gastroenterology & hepatologySurgeryNeoplasm stagingRadiologybusinessSurvival analysisR0 resectionHistological examinationArteryAnnals of Surgery
researchProduct

The actual management of colorectal liver metastases

2020

Colorectal cancer is one of the most frequent cancers in the world and between 50% and 60% of patients will develop colorectal liver metastases (CRLM) during the disease. There have been great improvements in the management of CRLM during the last decades. The combination of modern chemotherapeutic and biological systemic treatments with aggressive surgical resection strategies is currently the base for the treatment of patients considered unresectable until few years ago. Furthermore, several new treatments for the local control of CRLM have been developed and are now part of the arsenal of multidisciplinary teams for the treatment of these complex patients. The aim of this review was to s…

ReoperationSurgical resectionmedicine.medical_specialtyOrganoplatinum CompoundsColorectal cancerLeucovorinDisease030230 surgery03 medical and health sciencesHepatic Artery0302 clinical medicineAntineoplastic Combined Chemotherapy ProtocolsHepatectomyHumansInfusions Intra-ArterialMedicineMicrowavesRadiofrequency Ablationbusiness.industryGeneral surgeryLiver NeoplasmsMargins of ExcisionPrognosismedicine.diseaseLiver TransplantationElectroporation030220 oncology & carcinogenesisCamptothecinSurgeryFluorouracilColorectal NeoplasmsbusinessMinerva Chirurgica
researchProduct

Disconnected pancreatic duct syndrome: complete pancreas transection secondary to acute pancreatitis

2016

Disconnected pancreatic duct syndrome is a serious complication of acute pancreatitis which is defined by a complete discontinuity of the pancreatic duct, such that a viable side of the pancreas remains isolated from the gastrointestinal tract. This pancreatic disruption is infrequently observed in the clinical practice and its diagnostic and therapeutic management are controversial. We present an extreme case of disconnected pancreatic duct syndrome with complete duct disruption and pancreatic transection following acute pancreatitis, as well as the diagnostic and therapeutic processes carried out.

medicine.medical_specialtyPancreatic pseudocysteducation030230 surgeryGastroenterology03 medical and health sciences0302 clinical medicineInternal medicineMedicineHumanslcsh:RC799-869PancreasPancreatic ductCholangiopancreatography Endoscopic RetrogradeGastrointestinal tractbusiness.industryGastroenterologyPancreatic DuctsGeneral MedicineMiddle Agedmedicine.diseaseAdenocarcinoma MucinousMagnetic Resonance ImagingPancreatic Neoplasmsmedicine.anatomical_structurePancreatitisAcute pancreatitisPancreatitis030211 gastroenterology & hepatologyFemalelcsh:Diseases of the digestive system. GastroenterologybusinessPancreasComplicationTomography X-Ray ComputedDuct (anatomy)Revista Espanola de Enfermedades Digestivas
researchProduct

Impact of type and severity of postoperative complications on long‐term outcomes after colorectal liver metastases resection

2020

Background and objectives Postoperative complications (POCs) after hepatic resection for colorectal liver metastases (CRLM) adversely affect long-term survival. The aim of this study was to analyze the effect of POC etiology and severity on overall survival (OS) and disease-free survival (DFS). Methods A retrospective study of 254 consecutive hepatectomies for CRLM was performed. Univariate and multivariate analyses were performed to determine the effects of demographic, tumor-related and perioperative variables on OS and DFS. A 1:1 propensity score matching (PSM) was then used to compare patients with different POC etiology: infective (Inf-POC), noninfective (Non-inf POC), and no-complicat…

Malemedicine.medical_specialtyMultivariate analysisColorectal cancerGastroenterologyDisease-Free SurvivalResectionCohort Studies03 medical and health sciencesPostoperative Complications0302 clinical medicineInternal medicineparasitic diseasesLong term outcomesmedicineHepatectomyHumansPropensity ScoreAgedRetrospective Studiesbusiness.industryLiver NeoplasmsRetrospective cohort studyGeneral MedicinePerioperativeMiddle Agedmedicine.diseaseSurvival RateOncologySpain030220 oncology & carcinogenesisPropensity score matchingEtiologyFemale030211 gastroenterology & hepatologySurgeryColorectal NeoplasmsbusinessJournal of Surgical Oncology
researchProduct